Denmark has officially legalized medical cannabis after years of trial use. A program launched in 2018 allowed doctors to prescribe cannabis to patients who hadn’t found relief with other treatments.
Initially set to run until 2025, the trial has now been made permanent thanks to strong parliamentary support.
The law primarily benefits patients with conditions like multiple sclerosis, spinal cord injuries, cancer, or chronic pain. Social Minister Sophie Løhde highlighted its impact: “Many people experience less pain or nausea, which can significantly improve the quality of life.” She added, “This agreement ensures patients who haven’t had success with other medicines can safely access medical cannabis in the future.”
However, not everyone is on board. Some doctors have expressed concerns, citing a lack of information about the drug’s effectiveness and potential side effects, which has made them hesitant to prescribe it.
Meanwhile, Sweden approved its first cannabis-based medication, Sativex, in 2011. This oral spray treats spasticity in multiple sclerosis patients. By 2021, prescriptions for Sativex in Sweden had surged by nearly 60%, reflecting a growing acceptance of cannabis-based treatments.
